Formulations of morphine sulphate are easily confused

BMJ 1996; 313 doi: https://doi.org/10.1136/bmj.313.7058.687b (Published 14 September 1996) Cite this as: BMJ 1996;313:687
  1. Gillian F Cavell, Principal pharmacist
  1. King's College Hospital, London SE5 9RS

    EDITOR,—The recommendations for the use of morphine in cancer pain produced by the Expert Working Group of the European Association for Palliative Care provide a comprehensive framework that will be of benefit to all health care professionals caring for this group of patients.1 Prescribing morphine sulphate may, however, give rise to problems. The current edition of the British National Formulary lists several proprietary oral preparations of morphine sulphate, including liquid, sustained release, …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription